Forty Seven, Inc.
IPO News: Subject: Filed S-1/A: Forty Seven, Inc. Launches 6.7mm Share IPO with $14.00 - $16.00 Marketing Range
Forty Seven, Inc.

Forty Seven, Inc.

NASDAQ: FTSV

Initial Filing Date: 06/01/18

Launch Date: 06/18/18

Price Range: $14.00 - $16.00

Shares Offered (Pre-Shoe, mm): 6.7

Primary Shares (mm): 6.7

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint) (mm): $100.5

% Secondary: 0.0%

Shares Outstanding (mm): 29.6

Market Value (@ Midpoint) (mm): $444.4

Offering as % of Market Value: 22.6%

Bookrunners: Morgan Stanley | Credit Suisse

Co-Managers: Canaccord | BTIG | Oppenheimer

Major Holders: Lightspeed Ventures Partners | Sutter Hill Ventures | Clarus Lifesciences | Wellington Management | GV | Executives & Directors

Description: Forty Seven, Inc. is a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer.

Note: Emerging Growth Company

 

Reference Links: S-1/A